Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm
March 27, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
March 22, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)
March 20, 2023 01:45 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Amgen Inc.? If so, please visit Amgen Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, Credit Suisse, SVB, and Amgen and Encourages Investors to Contact the Firm
March 17, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for SIVB, AMGN, and SBNY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 17, 2023 12:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 17, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Amgen Inc. (NASDAQ: AMGN)
March 15, 2023 16:00 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Amgen Inc.? If so, please visit Amgen Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your...
Cell and Gene Therapy Market accounted for US$ 2.38 billion in 2020 and is projected to register CAGR of 35.50% - By PMI
January 16, 2023 10:08 ET
|
PMI
Covina, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Cell therapy and gene therapy are fields of biomedical research and treatment, both therapies aim to treat, prevent, or potentially cure diseases, and both...
Revolution Medicines Doses First Patient in Phase 1/1b Clinical Trial of RMC-6291, Company’s First Mutant-Selective RAS(ON) Inhibitor
September 22, 2022 07:00 ET
|
Revolution Medicines, Inc.
KRASG12C(ON) Inhibitor with highly differentiated mechanism of action being evaluated in patients with cancers harboring KRASG12C mutation RMC-6291 is first mutant-selective RAS(ON) Inhibitor to...
Arthritis Foundation President and CEO Steven Taylor Rides Out with 22nd Annual California Coast Classic Presented by Amgen
September 12, 2022 09:00 ET
|
The Arthritis Foundation’s California Coast Classic Bicycle Tour
SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Arthritis Foundation President and Chief Executive Officer Steven Taylor joined riders of The California Coast Classic + Arthritis Challenge...
CHEMOCENTRYX, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CCXI and Encourages Investors to Contact the Firm
August 07, 2022 20:05 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 07, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...